[(2S,4S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl] (1S,3R,6S,7S,12S,14R,15R,16R)-14-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-[(2R,4S,5R)-4,5-dihydroxy-6-methyl-3-[(2S,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,12,16-trimethyl-15-[(2R)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylate
| Internal ID | beba954c-7e0d-4117-8801-3efdde395e48 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins > Cucurbitacin glycosides |
| IUPAC Name | [(2S,4S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl] (1S,3R,6S,7S,12S,14R,15R,16R)-14-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-[(2R,4S,5R)-4,5-dihydroxy-6-methyl-3-[(2S,3S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,12,16-trimethyl-15-[(2R)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylate |
| SMILES (Canonical) | CC1C(C(C(C(O1)OC(=O)C2(C3CCC4C5(CC(C(C5(CCC46C3(C6)CCC2OC7C(C(C(C(O7)C)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)C(C)CCC=C(C)C)OC9C(C(C(O9)CO)O)O)C)C)O)O)O |
| SMILES (Isomeric) | CC1[C@@H]([C@@H](C([C@@H](O1)OC(=O)[C@@]2([C@H](CC[C@@]34C2CCC5[C@@]3(C4)CC[C@]6([C@]5(C[C@H]([C@@H]6[C@H](C)CCC=C(C)C)O[C@H]7C([C@H]([C@H](O7)CO)O)O)C)C)O[C@H]8C([C@H]([C@H](C(O8)C)O)O)O[C@H]9[C@H](C([C@@H](C(O9)CO)O)O)O)C)O)O)O |
| InChI | InChI=1S/C53H86O21/c1-22(2)10-9-11-23(3)32-26(69-45-40(63)36(59)28(20-55)70-45)18-50(7)29-12-13-30-51(8,48(66)74-44-41(64)37(60)33(56)24(4)67-44)31(14-15-52(30)21-53(29,52)17-16-49(32,50)6)72-47-43(39(62)34(57)25(5)68-47)73-46-42(65)38(61)35(58)27(19-54)71-46/h10,23-47,54-65H,9,11-21H2,1-8H3/t23-,24?,25?,26-,27?,28-,29?,30?,31+,32+,33+,34+,35-,36+,37+,38?,39+,40?,41?,42+,43?,44+,45-,46+,47+,49-,50+,51+,52-,53+/m1/s1 |
| InChI Key | DTVJERQJXPAODQ-QBGDHTETSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C53H86O21 |
| Molecular Weight | 1059.20 g/mol |
| Exact Mass | 1058.56615975 g/mol |
| Topological Polar Surface Area (TPSA) | 334.00 Ų |
| XlogP | 2.20 |
| Atomic LogP (AlogP) | -0.37 |
| H-Bond Acceptor | 21 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 14 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7858 | 78.58% |
| Caco-2 | - | 0.8868 | 88.68% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.8429 | 84.29% |
| Subcellular localzation | Mitochondria | 0.8138 | 81.38% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8269 | 82.69% |
| OATP1B3 inhibitior | + | 0.8678 | 86.78% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.6500 | 65.00% |
| BSEP inhibitior | + | 0.8917 | 89.17% |
| P-glycoprotein inhibitior | + | 0.7528 | 75.28% |
| P-glycoprotein substrate | + | 0.5088 | 50.88% |
| CYP3A4 substrate | + | 0.7249 | 72.49% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8541 | 85.41% |
| CYP3A4 inhibition | - | 0.9395 | 93.95% |
| CYP2C9 inhibition | - | 0.7289 | 72.89% |
| CYP2C19 inhibition | - | 0.8433 | 84.33% |
| CYP2D6 inhibition | - | 0.9250 | 92.50% |
| CYP1A2 inhibition | - | 0.8420 | 84.20% |
| CYP2C8 inhibition | + | 0.6240 | 62.40% |
| CYP inhibitory promiscuity | - | 0.8748 | 87.48% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.9900 | 99.00% |
| Carcinogenicity (trinary) | Non-required | 0.6206 | 62.06% |
| Eye corrosion | - | 0.9887 | 98.87% |
| Eye irritation | - | 0.9035 | 90.35% |
| Skin irritation | - | 0.6279 | 62.79% |
| Skin corrosion | - | 0.9380 | 93.80% |
| Ames mutagenesis | - | 0.7878 | 78.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7729 | 77.29% |
| Micronuclear | - | 0.8000 | 80.00% |
| Hepatotoxicity | - | 0.8290 | 82.90% |
| skin sensitisation | - | 0.8813 | 88.13% |
| Respiratory toxicity | + | 0.5222 | 52.22% |
| Reproductive toxicity | + | 0.8333 | 83.33% |
| Mitochondrial toxicity | - | 0.5125 | 51.25% |
| Nephrotoxicity | - | 0.8949 | 89.49% |
| Acute Oral Toxicity (c) | I | 0.4458 | 44.58% |
| Estrogen receptor binding | + | 0.8154 | 81.54% |
| Androgen receptor binding | + | 0.7580 | 75.80% |
| Thyroid receptor binding | - | 0.4882 | 48.82% |
| Glucocorticoid receptor binding | + | 0.7527 | 75.27% |
| Aromatase binding | + | 0.6470 | 64.70% |
| PPAR gamma | + | 0.8095 | 80.95% |
| Honey bee toxicity | - | 0.6185 | 61.85% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.6155 | 61.55% |
| Fish aquatic toxicity | + | 0.9709 | 97.09% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.30% | 91.11% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.74% | 94.45% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 96.02% | 95.58% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.41% | 96.09% |
| CHEMBL2581 | P07339 | Cathepsin D | 93.92% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 92.09% | 96.61% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.00% | 96.61% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 91.89% | 97.25% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 90.73% | 89.00% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 90.61% | 91.24% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.53% | 91.19% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 89.46% | 97.09% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 88.43% | 95.69% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 88.30% | 98.75% |
| CHEMBL4683 | Q12884 | Fibroblast activation protein alpha | 88.19% | 93.07% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 88.10% | 91.49% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 88.08% | 94.75% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 87.50% | 100.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 87.38% | 95.50% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 87.27% | 95.83% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.10% | 95.89% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 87.09% | 97.47% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 86.98% | 96.03% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 86.19% | 92.88% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.13% | 93.56% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 86.06% | 96.38% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 86.05% | 96.00% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 86.00% | 89.50% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 85.37% | 92.94% |
| CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 85.18% | 92.78% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 84.95% | 98.10% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.66% | 97.50% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.36% | 100.00% |
| CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 84.24% | 100.00% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 83.70% | 95.36% |
| CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 83.56% | 92.62% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.15% | 100.00% |
| CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 82.70% | 97.36% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.55% | 94.33% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 82.40% | 99.00% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 82.36% | 95.50% |
| CHEMBL4105786 | P41182 | B-cell lymphoma 6 protein | 82.19% | 92.86% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 81.86% | 96.47% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 81.70% | 92.50% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 80.61% | 86.33% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 80.25% | 82.50% |
| CHEMBL233 | P35372 | Mu opioid receptor | 80.20% | 97.93% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Amphilophium paniculatum |
| PubChem | 162867142 |
| LOTUS | LTS0263078 |
| wikiData | Q104989042 |